Atrasentan received FDA approval for IgA nephropathy, reducing proteinuria by 36% and showing consistent efficacy across diverse patient groups. Value-based care programs significantly slowed CKD ...
Researchers at the University of Cincinnati College of Medicine have created a scoring model that uses key health indicators to accurately predict recovery for patients who experience kidney failure ...
March is Kidney Disease Awareness Month and many people, especially those with diabetes or who are on dialysis may have concerns about their feet and kidney disease. Chronic kidney disease, ...
Incidental detection has increased with ubiquitous CT/MRI, inflating early-stage ‘small renal mass’ diagnoses and complicating interpretation of a ~5% rise in <50-year incidence. Obesity, hypertension ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results